<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03167866</url>
  </required_header>
  <id_info>
    <org_study_id>66666</org_study_id>
    <nct_id>NCT03167866</nct_id>
  </id_info>
  <brief_title>Effect of Motivation Text Messages on Diabetes Patients</brief_title>
  <official_title>The Influence of Motivational Text Messages on Glycemic Control and Healthy Lifestyle Choices in Patients With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will examine the influence of increasing motivation on healthy lifestyle
      and glycemic control in diabetes patients. Participants will be randomized to two groups, the
      control group gets informational text message and the intervention group gets motivational
      SMS. The patients get a weekly text message and after 26 weeks the HbA1c and quality of life
      will be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will examine the influence of increasing motivation on healthy lifestyle
      and glycemic control in diabetes patients. Participants will provide demographic and clinical
      information, fill human value questionnaires and quality of life questionnaires and decide on
      personal lifestyle-improvement goals. They will then be randomized to one of two groups: the
      control group gets informational text message and the intervention group gets motivational
      text message. The patients get a weekly text message and after 26 weeks we will check the
      HbA1c and quality of life. The text message will be personalized by including personal
      details acquired by a questionnaire. They will provide demographic and clinical information.

      In addition, the influence of demographic characters and related DM character on the benefit
      of the motivational SMS will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Randomization will be by study personell that is not in contact with participants</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c levels at 6 months from beginning of messages</measure>
    <time_frame>at 6 months from beginning of study</time_frame>
    <description>Blood HbA1c levels are reflective of how well diabetes is controlled</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes Quality of Life questionnaire</measure>
    <time_frame>at 6 months from beginning of study</time_frame>
    <description>To design and test the reliability and validity of a brief treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>DM patients who receive a weekly informational Short Message Service (SMS) by phone for 26 weeks. informational SMS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>test group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DM patients who receive a weekly motivational Short Message Service (SMS) for 26 weeks. motivational SMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>motivational SMS</intervention_name>
    <description>the participant receives a weekly text message that is aimed to increase motivation</description>
    <arm_group_label>test group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>informational SMS</intervention_name>
    <description>the participant a weekly text message that is provides information on improving lifestyle</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uncontrolled DM 2 patients (HbA1c &gt; 8%)

          -  Know to read (Hebrew or Arabic)

          -  Have a cellular phone

          -  Can sign informed consent.

        Exclusion Criteria:

          -  A life expectancy of less than one year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irit Hochberg, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Healthcare Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Irit Hochberg, MD/PhD</last_name>
    <phone>972-4-7772150</phone>
    <email>i_hochberg@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Text message program improves outcomes, decreases ED utilization among ED patients with poorly controlled diabetes. ED Manag. 2014 Feb;26(2):20-3.</citation>
    <PMID>24505864</PMID>
  </reference>
  <reference>
    <citation>Reinhardt JA, van der Ploeg HP, Grzegrzulka R, Timperley JG. lmplementing lifestyle change through phone-based motivational interviewing in rural-based women with previous gestational diabetes mellitus. Health Promot J Austr. 2012 Apr;23(1):5-9.</citation>
    <PMID>22730940</PMID>
  </reference>
  <reference>
    <citation>Arora S, Peters AL, Agy C, Menchine M. A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program. Diabetes Technol Ther. 2012 Jun;14(6):492-6. doi: 10.1089/dia.2011.0252. Epub 2012 Apr 23.</citation>
    <PMID>22524591</PMID>
  </reference>
  <reference>
    <citation>Hochberg I, Feraru G, Kozdoba M, Mannor S, Tennenholtz M, Yom-Tov E. Encouraging Physical Activity in Patients With Diabetes Through Automatic Personalized Feedback via Reinforcement Learning Improves Glycemic Control. Diabetes Care. 2016 Apr;39(4):e59-60. doi: 10.2337/dc15-2340. Epub 2016 Jan 28.</citation>
    <PMID>26822328</PMID>
  </reference>
  <reference>
    <citation>Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2013 Nov;1(3):191-8. doi: 10.1016/S2213-8587(13)70067-6. Epub 2013 Sep 11.</citation>
    <PMID>24622367</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>May 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2017</study_first_posted>
  <last_update_submitted>May 24, 2017</last_update_submitted>
  <last_update_submitted_qc>May 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

